Answers are grounded in this paper and cite their sources.
Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary hepatic cancer in the United States. Currently, curative treatment involves aggressive surgery. Chemotherapy and radiation treatments have been used for unresectable tumors with some success. Optimizing the use of current and developing novel multimodality treatment for iCCA is essential to improving outcomes.
No takes yet. Share an insight, caveat, or question.
Simo et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: